McIntyre L, Huertas F, Morse A, Kaletsky R, Murphy C, Kalia V, Miller G, Moskalenko O, Conesa A, Mor D. GAIT-GM integrative cross-omics analyses reveal cholinergic defects in a C. elegans model of Parkinson’s disease. Sci Rep. 2022;12(1):3268. PMCID: PMC8885929

Mor D, Sohrabi S, Kaletsky R, Keyes W, Tartici A, Kalia V, Miller G, Murphy C. Metformin rescues Parkinson’s disease phenotypes caused by hyperactive mitochondria. Proc Natl Acad Sci U S A. 2020;117(42):26438–26447. PMCID: PMC7585014

Vizcarra J, Sánchez-Ferro Álvaro, Maetzler W, Marsili L, Zavala L, Lang A, Martinez-Martin P, Mestre T, Reilmann R, Hausdorff J, Dorsey R, Paul S, Dexheimer J, Wissel B, Fuller R, Bonato P, Tan A, Bloem B, Kopil C, Daeschler M, Bataille L, Kleiner G, Cedarbaum J, Klucken J, Merola A, Goetz C, Stebbins G, Espay A, MDS Technology Task Force and the MDS Rating Scales Program Electronic Development Ad-Hoc Committee. The Parkinson’s disease e-diary: Developing a clinical and research tool for the digital age. Mov Disord. 2019;34(5):676–681. PMCID: PMC8114172

Yan R, Zhang J, Park H-J, Park E, Oh S, Zheng H, Junn E, Voronkov M, Stock J, Mouradian M. Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson’s disease and DLB. Proc Natl Acad Sci U S A. 2018;115(51):E12053-E12062. PMCID: PMC6304960

Chikina M, Gerald C, Li X, Ge Y, Pincas H, Nair V, Wong A, Krishnan A, Troyanskaya O, Raymond D, Saunders-Pullman R, Bressman S, Yue Z, Sealfon S. Low-variance RNAs identify Parkinson’s disease molecular signature in blood. Mov Disord. 2015;30(6):813–21. PMCID: PMC4439364